Investment Management
* Sun Pharmaceutical Industries Ltd., India’s largest drugmaker by market value, agreed to buy Ranbaxy Laboratories Ltd. for $3.2 billion in stock, the biggest purchase by an Indian company in two years. * Ranbaxy investors will get 0.8 share in Sun for every one of their shares, the two companies said today in a statement. That’s equal to about 457 […]
* Since 11 Mar 2014, when Facebook traded at a record high of $72.59, the stock has declined 17.33% to close at $60.01 on Friday, 28 Mar 2014 * Mark Zuckerberg, the 29-year-old co-founder of Facebook Inc., lost $3.1 billion this week amid a decline in bank and technology stocks. * The world’s largest social […]
* Ford March U.S. light-vehicle sales up 3.3% vs est. up 1.1%. * Ford brand sales up 2.6%; Lincoln brand sales up 31.4% * Car sales up 2.6%; utilities up 3.6%; trucks up 4.1% * Ford Motor Co.’s Fusion sedan reached record sales this month as the automaker raised the model’s incentives 32 percent to meet growing competition in the contested […]
* CELG develops and commercializes therapies designed to treat cancer and immune/inflammatory diseases. CELG is fully integrated worldwide. Its main revenue driver is Revlimid for multiple myeloma and other hematological disorders * On Fri, Mar 21 2014, the FDA announced the approval of Otezla (apremilast) in psoriatic arthritis, which was in line with our expectations, given robust phase […]
* On 6 Mar 2014, we advised to Buy AUD/USD between $0.9050 and $0.9100. Target: $0.95. Time Horizon: 5 Months. Attainamble Profit: 4.50% * On 12 Mar 2014, AUD/USD traded as low as $0.8924 * On 26 Mar 2014, AUD/USD traded as high as $0.9235 * We mainatin our target price at $0.95 and advise […]
Sign up our newsletter for FREE financial advice and investment tips delivered to your inbox on weekly basis.
Want to keep in touch with news from Blue Phoenix Financials? Subscribe to our RSS feed using by clicking on the button to the right, or subscribe to our newsletter by filling out the form below.